Cargando…

Motor function performance in individuals with RYR1‐related myopathies

INTRODUCTION: The objective of this study was to obtain a 6‐month natural history of motor function performance in individuals with RYR1‐ related myopathy (RYR1‐RM) by using the Motor Function Measure‐32 (MFM‐32) and graded functional tests (GFT) while facilitating preparation for interventional tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Witherspoon, Jessica W., Vuillerot, Carole, Vasavada, Ruhi P., Waite, Melissa R., Shelton, Monique, Chrismer, Irene C., Jain, Minal S., Meilleur, Katherine G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619391/
https://www.ncbi.nlm.nih.gov/pubmed/31004442
http://dx.doi.org/10.1002/mus.26491
_version_ 1783433922506391552
author Witherspoon, Jessica W.
Vuillerot, Carole
Vasavada, Ruhi P.
Waite, Melissa R.
Shelton, Monique
Chrismer, Irene C.
Jain, Minal S.
Meilleur, Katherine G.
author_facet Witherspoon, Jessica W.
Vuillerot, Carole
Vasavada, Ruhi P.
Waite, Melissa R.
Shelton, Monique
Chrismer, Irene C.
Jain, Minal S.
Meilleur, Katherine G.
author_sort Witherspoon, Jessica W.
collection PubMed
description INTRODUCTION: The objective of this study was to obtain a 6‐month natural history of motor function performance in individuals with RYR1‐ related myopathy (RYR1‐RM) by using the Motor Function Measure‐32 (MFM‐32) and graded functional tests (GFT) while facilitating preparation for interventional trials. METHODS: In total, 34 participants completed the MFM‐32 and GFTs at baseline and 6‐month visits. RESULTS: Motor deficits according to MFM‐32 were primarily observed in the standing and transfers domain (D1; mean 71%). Among the GFTs, participants required the most time to ascend/descend stairs (>7.5 s). Functional movement, determined by GFT grades, was strongly correlated with MFM‐32 (D1; r ≥ 0.770, P < 0.001). Motor Function Measure‐32 and GFT scores did not reflect any change in performance between baseline and 6‐month visits. DISCUSSION: The MFM‐32 and GFTs detected motor impairment in RYR1‐RM, which remained stable over 6 months. Thus, these measures may be suitable for assessing change in motor function in response to therapeutic intervention. Muscle Nerve 60: 80–87, 2019
format Online
Article
Text
id pubmed-6619391
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-66193912019-07-22 Motor function performance in individuals with RYR1‐related myopathies Witherspoon, Jessica W. Vuillerot, Carole Vasavada, Ruhi P. Waite, Melissa R. Shelton, Monique Chrismer, Irene C. Jain, Minal S. Meilleur, Katherine G. Muscle Nerve Clinical Research Articles INTRODUCTION: The objective of this study was to obtain a 6‐month natural history of motor function performance in individuals with RYR1‐ related myopathy (RYR1‐RM) by using the Motor Function Measure‐32 (MFM‐32) and graded functional tests (GFT) while facilitating preparation for interventional trials. METHODS: In total, 34 participants completed the MFM‐32 and GFTs at baseline and 6‐month visits. RESULTS: Motor deficits according to MFM‐32 were primarily observed in the standing and transfers domain (D1; mean 71%). Among the GFTs, participants required the most time to ascend/descend stairs (>7.5 s). Functional movement, determined by GFT grades, was strongly correlated with MFM‐32 (D1; r ≥ 0.770, P < 0.001). Motor Function Measure‐32 and GFT scores did not reflect any change in performance between baseline and 6‐month visits. DISCUSSION: The MFM‐32 and GFTs detected motor impairment in RYR1‐RM, which remained stable over 6 months. Thus, these measures may be suitable for assessing change in motor function in response to therapeutic intervention. Muscle Nerve 60: 80–87, 2019 John Wiley & Sons, Inc. 2019-06-17 2019-07 /pmc/articles/PMC6619391/ /pubmed/31004442 http://dx.doi.org/10.1002/mus.26491 Text en © 2019 The Authors. Muscle & Nerve published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Research Articles
Witherspoon, Jessica W.
Vuillerot, Carole
Vasavada, Ruhi P.
Waite, Melissa R.
Shelton, Monique
Chrismer, Irene C.
Jain, Minal S.
Meilleur, Katherine G.
Motor function performance in individuals with RYR1‐related myopathies
title Motor function performance in individuals with RYR1‐related myopathies
title_full Motor function performance in individuals with RYR1‐related myopathies
title_fullStr Motor function performance in individuals with RYR1‐related myopathies
title_full_unstemmed Motor function performance in individuals with RYR1‐related myopathies
title_short Motor function performance in individuals with RYR1‐related myopathies
title_sort motor function performance in individuals with ryr1‐related myopathies
topic Clinical Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619391/
https://www.ncbi.nlm.nih.gov/pubmed/31004442
http://dx.doi.org/10.1002/mus.26491
work_keys_str_mv AT witherspoonjessicaw motorfunctionperformanceinindividualswithryr1relatedmyopathies
AT vuillerotcarole motorfunctionperformanceinindividualswithryr1relatedmyopathies
AT vasavadaruhip motorfunctionperformanceinindividualswithryr1relatedmyopathies
AT waitemelissar motorfunctionperformanceinindividualswithryr1relatedmyopathies
AT sheltonmonique motorfunctionperformanceinindividualswithryr1relatedmyopathies
AT chrismerirenec motorfunctionperformanceinindividualswithryr1relatedmyopathies
AT jainminals motorfunctionperformanceinindividualswithryr1relatedmyopathies
AT meilleurkatherineg motorfunctionperformanceinindividualswithryr1relatedmyopathies